MedTrace Logo

Inter- and Multidisciplinary, Cross-sectoral Feto-neonatal Pathway

NCT04514276 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 828

Last updated 2023-02-28

No results posted yet for this study

Summary

Due to the fetoneonatal pathway it is possible to identify pregnant women with an increased risk of fetal growth restriction or pre-eclampsia in early stages (from 10th week of pregnancy). Women whose pregnancy is considered high-risk receives risk-adapted prenatal treatment as well as certain treatments for their newborn and infant until 1 year of age. The tasks of all involved persons are defined by standard operating procedures (SOP)

Conditions

  • Pre-Eclampsia
  • Intrauterine Growth Restriction
  • Maternal Care for Known or Suspected Poor Fetal Growth

Interventions

OTHER

consecutive fetoneonatal healthcare pathway

(1) early perceiving of pregnant women with higher risks for early fetal growth restrictions via color Doppler sonography, fetal biometry, haemogram check (currently additional screenings) (2) structured care of the high risk women who are pregnant (3) concerted neonatal health care (4) adapted paediatric aftercare, certain dates and responsible persons are scheduled.

Sponsors & Collaborators

  • Jena University Hospital

    collaborator OTHER

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Mario Rüdiger, Prof. Dr · Technische Univeristät Dresden

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04514276 on ClinicalTrials.gov